Affiliation: University Hospital Birmingham
- Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfactionDawn Homer
Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, UK
Musculoskeletal Care 7:78-92. 2009..In this randomized trial we tested the feasibility of giving patients, who were about to start on a DMARD, information about the drug in groups and compared this with information given individually...
- Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse eventsParesh Jobanputra
Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, Raddlebarn Road, Birmingham, B29 6JD, UK
BMC Musculoskelet Disord 9:48. 2008..We report an investigation from a local surveillance for serious adverse drug reactions associated with disease modifying anti-rheumatic drugs that was triggered by the occurrence of liver failure in two of our patients...
- Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experienceParesh Jobanputra
Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Trust, Selly Oak, Birmingham, United Kingdom
Drug Saf 25:1099-105. 2002..We describe preliminary data from a regional surveillance scheme. Our aims were to identify a broad range of potential adverse events, to identify deficiencies in care and examine the management of common events in order to improve care...
- Patient self-injection of methotrexate for inflammatory arthritis: a study evaluating the introduction of a new type of syringe and exploring patients' sense of empowermentJennifer Hiley
University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
Musculoskeletal Care 6:15-30. 2008..To evaluate the introduction of a new type of syringe for patients on a self-injection of methotrexate (MTX) programme and explore patients' sense of empowerment relating to the self-injection of MTX...
- A study of parenteral use of methotrexate in rheumatic conditionsValerie Arthur
Rheumatology Department, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
J Clin Nurs 11:256-63. 2002..Patients were able to administer safely methotrexate subcutaneously. Self-administration reduced hospital visits, was more convenient for patients and improved patient satisfaction...